Combining basal insulin with a GLP-1 inhibitor not only may produce favorable reductions in A1c values, but may also lower the risk for hypoglycemia and promote weight loss, reports Dr John Buse.
Combining basal insulin with a GLP-1 inhibitor not only may produce favorable reductions in A1c values, but may also lower the risk for hypoglycemia and promote weight loss, reports Dr John Buse.